Procter & Gamble (P&G) for the nutritional supplement aisle.

Nestlé for health and sports nutrition brands.

Glanbia Performance Nutrition (makers of Optimum Nutrition), but also for general wellness and weight loss.

• Weight Loss Supplements: Products formulated to assist consumers with weight reduction and management.
• General Health Supplements: Nutritional supplements designed to support overall health and wellness.
• Sports Nutrition Supplements: Specialized formulations aimed at enhancing athletic performance, muscular development, and recovery for fitness enthusiasts and professionals.
• Men's Health Formulations: Dietary supplements created to address specific health concerns pertinent to men.
• Energy Products: Supplements and related products intended to boost energy levels.
• Meal Replacements: Formulated products that can be used as substitutes for traditional meals.

Dayton Judd, Chairman of the Board and Chief Executive Officer

Dayton Judd was appointed Chief Executive Officer of FitLife Brands in February 2018 and has also served as Chairman of the Board since June 2017. He is the founder and Managing Partner of Sudbury Capital Management (“Sudbury”), an investment fund that first invested in FitLife in 2012. Mr. Judd became a majority shareholder and stepped into the CEO role to lead a turnaround for the company. He also provided direct financing to the company through loans in late 2018. Before founding Sudbury, he was a Portfolio Manager at Q Investments, a multi-billion dollar hedge fund, from 2007 to 2011, and worked with McKinsey & Company from 1996 to 1998 and again from 2000 to 2007. Mr. Judd holds an MBA from Harvard Business School and Bachelor's and Master's degrees in accounting from Brigham Young University.

Jakob York, Chief Financial Officer

Jakob York serves as the Chief Financial Officer of FitLife Brands. He holds 0.9% of the company's common stock.

Jenna Sinnett, Chief Operating Officer

Jenna Sinnett is the Chief Operating Officer of FitLife Brands. She holds 0.4% of the company's common stock.

Ryan Hansen, Executive Vice President

Ryan Hansen serves as an Executive Vice President at FitLife Brands, joining the company in late 2023. He holds 3.9% of FitLife Brands' common stock.

Patrick Ryan, Chief Retail Officer

Patrick Ryan is the Chief Retail Officer for FitLife Brands. He holds 1.7% of the company's common stock.

Key Risks to FitLife Brands (FTLF)

For FitLife Brands (FTLF), the key risks to the business are primarily centered around its growth strategy, the highly competitive market it operates in, and its distribution model.

1. Reliance on Acquisitions for Growth and Associated Financial & Integration Risks

   FitLife Brands' growth strategy is heavily dependent on acquisitions rather than robust organic growth. This approach introduces substantial risks related to successfully integrating newly acquired brands, managing increased debt levels, and the potential for acquisitions to underperform or be overvalued. For instance, the acquisition of Irwin Naturals significantly increased the company's leverage. Reports indicate that organic sales in some segments have declined, further highlighting the company's reliance on M&A to avoid stagnation.

2. Intense Competition and Commoditization of the Nutritional Supplement Market

   FitLife Brands operates in a "red ocean" market characterized by intense competition, limited product differentiation, and low customer switching costs. This environment makes the company vulnerable to pricing pressures and rapidly shifting consumer preferences. The company is noted to lack significant proprietary intellectual property, economies of scale comparable to larger industry players, or strong network effects, relying instead on the perceived equity of its individual brands and retail relationships.

3. Dependence on Key Retail and Online Distribution Channels

   The company faces significant risks due to its reliance on third-party distribution channels, including major online retailers like Amazon and specialty stores such as GNC. This dependence exposes FitLife Brands to potential risks such as these platforms exerting pricing pressure or squeezing margins. Furthermore, declining wholesale sales resulting from lower foot traffic and store closures pose a threat to future revenue growth if not adequately offset by increased online sales.

The rise of highly effective prescription weight loss drugs, such as GLP-1 agonists (e.g., Ozempic, Wegovy, Mounjaro, Zepbound), represents a clear emerging threat. These medications offer a significantly more potent and medically supervised solution for weight loss compared to over-the-counter nutritional supplements. As these drugs gain wider adoption and acceptance, they could draw a substantial portion of consumers away from FitLife Brands' "weight loss" and "men's health and weight loss formulations" product categories, potentially eroding a core segment of the company's market.

FitLife Brands, Inc. operates in the nutritional supplements market, offering products across weight loss, general health, and sports nutrition categories. The addressable markets for these product lines exhibit significant global and regional sizes.

Weight Loss Supplements

The global weight loss supplement market was valued at approximately USD 37.89 billion in 2025 and is projected to reach about USD 140.16 billion by 2035, growing at a compound annual growth rate (CAGR) of 13.98% from 2026 to 2035. North America held a significant share of this global market, accounting for 37% in 2025. Specifically, the U.S. weight loss supplements market is anticipated to reach USD 17.23 billion by 2032.

General Health Supplements (Dietary Supplements)

The global dietary supplements market, which includes general health products such as vitamins, minerals, amino acids, enzymes, and herbs, was valued at USD 203.42 billion in 2025. This market is predicted to increase to approximately USD 430.39 billion by 2034, with a CAGR of 7.78% from 2026 to 2035. The U.S. dietary supplements market is projected to reach USD 190.08 billion by 2035.

Sports Nutrition Supplements

The global sports nutrition market size was valued at USD 71.55 billion in 2025 and is projected to reach USD 138.48 billion by 2033, exhibiting a CAGR of 8.7% from 2026 to 2033. North America was a dominant region in the global sports nutrition market, holding a revenue share of 47.70% in 2025. The U.S. sports nutrition market alone was valued at USD 15 billion in 2024.

Here are 3-5 expected drivers of future revenue growth for FitLife Brands (FTLF) over the next 2-3 years:

1. Strategic Acquisitions: The acquisition of Irwin Naturals in August 2025 is a significant driver, projected to nearly double the company's size and substantially increase its overall revenue, with a revised estimate for 2026 indicating a leap from $68.3 million to $130.8 million. The prior acquisition of MusclePharm in October 2023 also continues to contribute to growth.
2. New Product Launches and Innovation: FitLife Brands intends to launch several new products throughout 2024 across its various brands. This consistent focus on product innovation is expected to contribute to revenue growth.
3. Expansion in Mass Channels and Wholesale Growth: Management expresses confidence in expanding the company's brand presence in mass channels. This strategy is evidenced by a 156% year-over-year surge in wholesale revenue during Q3 2025, partially driven by the Irwin acquisition.
4. Growth in Online Sales: While online revenue for "Legacy FitLife" is not expected to see significant top-line growth in the near term, the MusclePharm brand has experienced considerable growth in Amazon subscribers. Furthermore, FitLife Brands aims to leverage its online selling expertise to support a robust growth trajectory, with Irwin's online sales growth also anticipated to improve its gross margin.
5. Price Increases: Planned price increases for MusclePharm products, set for January 2026, are expected to help offset rising whey protein costs and contribute to revenue.

Share Repurchases

• FitLife Brands had a 2025 Share Repurchase Program with $5,000 authorized as of September 30, 2025.
• By December 31, 2023, the company had completed the repurchase of 207,981 shares for $2.42 million under a buyback program announced in August 2019.
• Small share repurchases were made in 2021 and 2022, though these were not substantial enough to counteract new share issuances.

Share Issuance

• The number of shares outstanding increased by approximately 8% from 9.21 million to 9.39 million over a nine-month period, resulting in minor dilution for existing shareholders.
• As of November 12, 2025, a total of 9,391,072 shares of common stock were issued and outstanding.
• A 2-for-1 stock split was implemented on February 7, 2025, with all share and per-share information retroactively adjusted to reflect this change.

Outbound Investments

• FitLife Brands acquired Irwin Naturals in August 2025 for $42.5 million, an acquisition projected to approximately double FitLife's revenue in 2026.
• In 2023, the company completed two significant acquisitions: Mimi's Rock for $20 million in February and MusclePharm assets for $18.5 million in October, financed through non-dilutive means including debt and cash.
• The company's core strategy involves an M&A-driven "roll-up strategy" focused on acquiring and developing brands within the consumer health and wellness sector.

Capital Expenditures

• Capital expenditures were notably low, around $10,000 per quarter, as of early 2026, consistent with the company's "asset-light model" that relies on third-party contract manufacturers.
• In the last 12 months leading up to late 2025/early 2026, capital expenditures were reported at -$37,000.
• An exception to the generally low capital expenditures occurred in fiscal 2023, when they reached $18.9 million, contributing to a negative free cash flow alongside a $17.1 million cash outflow for acquisitions.